131.86
price up icon0.02%   0.02
pre-market  プレマーケット:  132.72   0.86   +0.65%
loading

Biogen Inc (BIIB) 最新ニュース

pulisher
07:00 AM

Biogen Disappointed by INESSS Recommendation on SKYCLARYS™ and its Impact on Quebec Patients with Friedreich Ataxia – Company AnnouncementFT.com - Financial Times

07:00 AM
pulisher
04:35 AM

Wealth Enhancement Advisory Services LLC Acquires 11,504 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat

04:35 AM
pulisher
Jun 04, 2025

Subcutaneous Biologics Market in 2025-2032 Detailed Study - openPR.com

Jun 04, 2025
pulisher
Jun 04, 2025

4,772 Shares in Biogen Inc. (NASDAQ:BIIB) Purchased by First County Bank CT - MarketBeat

Jun 04, 2025
pulisher
Jun 04, 2025

Czech National Bank Acquires 2,025 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Jun 04, 2025
pulisher
Jun 04, 2025

Rhumbline Advisers Increases Stock Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Jun 04, 2025
pulisher
Jun 04, 2025

Biogen Inc. (NASDAQ:BIIB) Shares Acquired by GAMMA Investing LLC - MarketBeat

Jun 04, 2025
pulisher
Jun 03, 2025

Biogen to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - Biogen

Jun 03, 2025
pulisher
Jun 03, 2025

Relapsing Remitting Multiple Sclerosis Market Set to Witness - openPR.com

Jun 03, 2025
pulisher
Jun 03, 2025

Biogen Inc (BIIB)'s Uncertain Future: Understanding the Barriers to Outperformance - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Ex-Biogen Chief Medical Officer Strengthens Entrada's Duchenne Program as Phase 1 Data Shows Promise - Stock Titan

Jun 03, 2025
pulisher
Jun 03, 2025

Neuromuscular Disease Therapeutics Market Growth Driven - openPR.com

Jun 03, 2025
pulisher
Jun 03, 2025

152,867 Shares in Biogen Inc. (NASDAQ:BIIB) Acquired by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat

Jun 03, 2025
pulisher
Jun 03, 2025

What is William Blair's Estimate for Biogen Q2 Earnings? - MarketBeat

Jun 03, 2025
pulisher
Jun 02, 2025

Lansforsakringar Fondforvaltning AB publ Makes New Investment in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Jun 02, 2025
pulisher
Jun 02, 2025

City Therapeutics Partners with Biogen - Global Legal Chronicle

Jun 02, 2025
pulisher
Jun 02, 2025

Biogen Inc. stock outperforms competitors on strong trading day - MarketWatch

Jun 02, 2025
pulisher
Jun 02, 2025

Biogen Inc. (NASDAQ:BIIB) Holdings Raised by Centre Asset Management LLC - MarketBeat

Jun 02, 2025
pulisher
Jun 01, 2025

California State Teachers Retirement System Buys 2,811 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Jun 01, 2025
pulisher
Jun 01, 2025

Biogen Inc. (NASDAQ:BIIB) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat

Jun 01, 2025
pulisher
Jun 01, 2025

Toronto Dominion Bank Has $11.11 Million Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Jun 01, 2025
pulisher
Jun 01, 2025

Lighthouse Financial LLC Acquires Shares of 2,100 Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Jun 01, 2025
pulisher
May 31, 2025

Farmers Trust Co. Acquires 2,012 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat

May 31, 2025
pulisher
May 30, 2025

Auxier Asset Management Sells 2,136 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat

May 30, 2025
pulisher
May 30, 2025

Q1 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks - Yahoo Finance

May 30, 2025
pulisher
May 30, 2025

Biogen Inc. (NASDAQ:BIIB) Shares Bought by Mackenzie Financial Corp - MarketBeat

May 30, 2025
pulisher
May 29, 2025

GF Fund Management CO. LTD. Makes New $5.24 Million Investment in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

May 29, 2025
pulisher
May 29, 2025

Progressive Supranuclear Palsy Treatment Market Set to Witness GrowthBiogen, AbbVie - openPR.com

May 29, 2025
pulisher
May 29, 2025

PKO Investment Management Joint Stock Co Takes Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

May 29, 2025
pulisher
May 29, 2025

Biogen and City Therapeutics partner to develop RNAi therapies - MSN

May 29, 2025
pulisher
May 29, 2025

Biogen Inc. (NASDAQ:BIIB) Shares Sold by USS Investment Management Ltd - MarketBeat

May 29, 2025
pulisher
May 29, 2025

Siemens Fonds Invest GmbH Grows Stock Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

May 29, 2025
pulisher
May 29, 2025

Public Employees Retirement System of Ohio Sells 2,866 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat

May 29, 2025
pulisher
May 29, 2025

Voloridge Investment Management LLC Invests $23.20 Million in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

May 29, 2025
pulisher
May 28, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $234.55 Million Stock Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

May 28, 2025
pulisher
May 28, 2025

Tauopathies Treatment Market Detailed in New Research ReportBiogen, AbbVie - openPR.com

May 28, 2025
pulisher
May 28, 2025

Amyotrophic lateral Sclerosis Market 2025-2032: Top Trends & - openPR.com

May 28, 2025
pulisher
May 28, 2025

Recombinant Dna Technology Market Generated Opportunities, - openPR.com

May 28, 2025
pulisher
May 28, 2025

In Vitro Monoclonal Antibodies Market is expected to reach US$ - openPR.com

May 28, 2025
pulisher
May 28, 2025

Biogen and City Therapeutics to develop RNAi therapy - Yahoo Finance

May 28, 2025
pulisher
May 28, 2025

Biogen and City Therapeutics partner to advance RNAi therapies - World Pharmaceutical Frontiers

May 28, 2025
pulisher
May 28, 2025

Biogen Inc. (NASDAQ:BIIB) Holdings Lifted by Quantinno Capital Management LP - MarketBeat

May 28, 2025
pulisher
May 28, 2025

Woodline Partners LP Boosts Stock Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

May 28, 2025
pulisher
May 27, 2025

Biogen’s SWOT analysis: stock faces challenges amid neuroscience potential - Investing.com

May 27, 2025
pulisher
May 27, 2025

Biogen’s SWOT analysis: stock faces challenges amid neuroscience potential By Investing.com - Investing.com UK

May 27, 2025
pulisher
May 27, 2025

Biogen Inc. (BIIB) Taps RNAi Therapy in City Therapeutics Deal - Yahoo Finance

May 27, 2025
pulisher
May 27, 2025

Biogen (NasdaqGS:BIIB) Partners With City Therapeutics in US$1 Billion RNAi Therapy Deal - simplywall.st

May 27, 2025
drug_manufacturers_general PFE
$23.39
price up icon 0.17%
$109.02
price down icon 0.28%
$287.01
price down icon 0.88%
drug_manufacturers_general GSK
$40.80
price up icon 0.84%
drug_manufacturers_general MRK
$78.27
price up icon 1.46%
drug_manufacturers_general NVO
$72.04
price up icon 1.59%
大文字化:     |  ボリューム (24 時間):